Researchers have discovered a potential way around the production of epiretinal membranes, a major adverse event in the use of induced pluripotent stem cells, to treat AMD.
Researchers have discovered a potential way around the production of epiretinal membranes, a major adverse event in the use of induced pluripotent stem cells, to treat AMD.
